Answers are grounded in this paper and cite their sources.
This work was designed to evaluate the efficacy of a postbiotic compound produced by stabilized non-viable Lactobacilli on the health, growth performance, immunity, and gut status against Escherichia coli ( E. coli ) challenge of broiler chickens. A total of 400, day-old broiler chicks were allocated into 4 equal groups (1-4) consisting of 100; each assigned into 2 equal replicates (50 each). Chickens in the 1st group were received the dry form of the compound at doses of 1 kg and 0.5 kg /ton feed for starter and grower, and the finisher diets; respectively. Chickens in the 2nd group were given the aqueous form of the compound in a dose of 4 ml/liter of the drinking water during the first 3 days of life and at a day before and after each vaccination. Feed and water treatments regimens were administered to chickens in the 3rd group. Group (4) was kept without treatment. Each bird in the 1st, 2nd, 3rd, and 4th group was challenged with E. coli (O78) at one-week-old. All groups were kept under observation till 5-week-old. The results indicated that both treatments with the postbiotic compound induced more significant (P≤ 0.05) amelioration of a disease picture, enhancement of growth performance, boosting of immune response, improvement of bursa/body weight ratio, and reduction of intestinal coliform count in challenged chickens when compared with challenged non-treated chickens. In conclusion, the posbiotic compound either in a dry and/or an aqueous form is recommended for improving the health, performance, and immunity of colisepticaemic broiler chickens.
No takes yet. Share an insight, caveat, or question.
El‐Ghany et al. (2022) studied this question.